DEER PARK, Ill., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases and ANI Pharmaceuticals, Inc (Nasdaq: ANIP), a bio-pharmaceutical company serving patients in need through the development and manufacturing of high-quality generic and branded medicines, today announced the commercial launch of Carglumic Acid tablets.
DEER PARK, Ill., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. marketing rights to carglumic acid tablets
Novitium Pharma’s Generics Metronidazole Receives Approvals In US
Lucane Pharma’s Ucedane (Carglumic Acid) Receives Approval In Europe
Dipharma Announces Successful development of a stable, fast dissolving tablet Formulation of carglumic acid